Showing results (571-580 of 586) with videos related to

Sort By:
Pageof 59
The Lancet. Oncology|July 3, 2026
Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS)Christophe M Deroose, Hannes Leupe, Rodney J Hicks, et al.
Science Advances|October 27, 2023
Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolutionLaura M Bartos, Sabrina V Kirchleitner, Zeynep Ilgin Kolabas, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 14, 2021
Value of PET imaging for radiation therapyConstantin Lapa, Ursula Nestle, Nathalie L Albert, et al.
Nuklearmedizin. Nuclear Medicine|July 14, 2021
Value of PET imaging for radiation therapyConstantin Lapa, Ursula Nestle, Nathalie L Albert, et al.
The Journal of Experimental Medicine|April 20, 2017
Detection of interferon alpha protein reveals differential levels and cellular sources in diseaseMathieu P Rodero, Jérémie Decalf, Vincent Bondet, et al.
Neuro-Oncology|May 3, 2025
Response Assessment in Neuro-Oncology (RANO) 2009-2025: Broad Scope and Implementation - A Progress ReportMartin J van den Bent, Michael A Vogelbaum, Tim Cloughesy, et al.
The Lancet. Oncology|July 31, 2025
Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomasNorbert Galldiks, Philipp Lohmann, Mariam Aboian, et al.
Molecular Psychiatry|July 26, 2023
Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathiesAnika Finze, Gloria Biechele, Boris-Stephan Rauchmann, et al.
Molecular Neurodegeneration|September 5, 2024
Regional desynchronization of microglial activity is associated with cognitive decline in Alzheimer's diseaseArtem Zatcepin, Johannes Gnörich, Boris-Stephan Rauchmann, et al.
Neuro-Oncology|August 19, 2025
Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future DirectionsPatrick Y Wen, Michael Weller, Eudocia Q Lee, et al.
Pageof 59